Allosteric Effects of Sodium Ion Binding on Activation of the M3 Muscarinic G-Protein-Coupled Receptor  by Miao, Yinglong et al.
1796 Biophysical Journal Volume 108 April 2015 1796–1806ArticleAllosteric Effects of Sodium Ion Binding on Activation of the M3Muscarinic
G-Protein-Coupled ReceptorYinglong Miao,1,* Alisha D. Caliman,2 and J. Andrew McCammon1,2,3
1Howard Hughes Medical Institute, 2Department of Pharmacology, and 3Department of Chemistry and Biochemistry, University of California at
San Diego, La Jolla, CaliforniaABSTRACT G-protein-coupled receptors (GPCRs) are important membrane proteins that mediate cellular signaling and
represent primary targets for about one-third of currently marketed drugs. Recent x-ray crystallographic studies identified distinct
conformations of GPCRs in the active and inactive states. An allosteric sodium ion was found bound to a highly conserved D2.50
residue in inactive GPCRs, whereas the D2.50 allosteric pocket became collapsed in active GPCR structures. However, the
dynamic mechanisms underlying these observations remain elusive. In this study, we aimed to understand the mechanistic ef-
fects of sodium ion binding on dynamic activation of the M3 muscarinic GPCR through long-timescale accelerated molecular
dynamics (aMD) simulations. Results showed that with the D2.50 residue deprotonated, the M3 receptor is bound by an allo-
steric sodium ion and confined mostly in the inactive state with remarkably reduced flexibility. In contrast, the D2.50-protonated
receptor does not exhibit sodium ion binding to the D2.50 allosteric site and samples a significantly larger conformational space.
The receptor activation is captured and characterized by large-scale structural rearrangements of the transmembrane helices
via dynamic hydrogen bond and salt bridge interactions. The residue motions are highly correlated during receptor activation.
Further network analysis revealed that the allosteric signaling between residue D2.50 and key residues in the intracellular, extra-
cellular, and orthosteric pockets is significantly weakened upon sodium ion binding.INTRODUCTIONMuscarinic acetylcholine receptors belong to the superfam-
ily of G-protein-coupled receptors (GPCRs), which are
important cellular signaling proteins and represent primary
targets of about one-third of currently marketed drugs (1).
M3, one of five subtypes of the muscarinic receptors, pref-
erentially couples with the Gq/11 proteins and stimulates
the metabolism of phospholipids and calcium release. The
M3 receptor has been targeted for treating many human dis-
eases, including cancer (2), diabetes (3), and obesity (4).
Like many other GPCRs, the M3 muscarinic receptor ex-
hibits a certain level of basal activity even without binding
any agonists (5). This suggests that the ligand-free receptor
exists in an ensemble of different conformations. Binding
of agonists and inverse agonists in the orthosteric site biases
the receptor conformational equilibrium toward the active
and inactive states, respectively. The receptor is also able to
bind neutral antagonists that have no signaling effects but
just block the receptor from binding other ligands, as well
as partial agonists that induce only submaximal activity (5).
The x-ray structure of the M3 muscarinic receptor has
been determined in an inactive state bound by the tiotropium
(TTP) antagonist (6). The M3 receptor consists of seven
transmembrane (TM) helices that are connected by six alter-
nating extracellular and intracellular loops (ECL1–ECL3Submitted December 8, 2014, and accepted for publication March 4, 2015.
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0006-3495/15/04/1796/11 $2.00and ICL1–ICL3). Compared with the inactive M2 receptor,
the M3 receptor exhibits a highly conserved orthosteric
site in the TM domain and inward displacement of the
cytoplasmic end of the TM5 helix toward TM6 by ~4 A˚.
Although the x-ray structure has provided important insights
into the structural scaffold of the M3 receptor and atomistic
receptor-antagonist interactions, the active structure of the
M3 receptor is still lacking and the dynamic mechanisms
of the receptor activation remain unclear.
To date, x-ray crystallographic studies have revealed
active structures of three other GPCRs: 1) rhodopsin, as in
an activated form of apo opsin (7,8) and in the active meta-
rhodopsin II state (9,10); 2) the b2-adrenergic receptor
(b2AR) (11,12); and 3) the M2 muscarinic receptor (13).
These active structures are characterized by opening of
the G-protein-coupling site through rearrangements of the
TM5, TM6, and TM7 helices relative to the inactive config-
uration. The cytoplasmic end of TM6 is tilted outward by
~10–14 A˚ when coupled to the G-protein (11) or G-pro-
tein-mimetic nanobody (12,13), and a smaller magnitude
of ~6–7 A˚ in the absence of the G-protein (7). Correspond-
ingly, the R3.50-E6.30 salt bridge, identified as the ionic
lock in many inactive GPCRs, is broken. Moreover, the
Y5.58 and Y7.53 residues relocate their side chains toward
each other and form close interactions in the intracellular
pocket (7,8,11,12). The Ballesteros-Weinstein numbering
scheme (14) is used for residues in the TM helices as
LN.XX, where L is the one-letter residue name, N is thehttp://dx.doi.org/10.1016/j.bpj.2015.03.003
M3 GPCR Activation and Sodium Binding 1797TM helix number, and XX is the residue number relative to
the most conserved residue (assigned as 50) in the TM helix,
with the number decreasing toward the N-terminus and
increasing toward the C-terminus.
Binding of an allosteric sodium ion to the D2.50 residue
has also been observed in the x-ray structures of several
inactive GPCRs, including the human A2A adenosine recep-
tor (A2AAR) (15), b1-adrenergic receptor (b1AR) (16),
protease-activated receptor 1 (PAR1) (17), and d-opioid re-
ceptor (d-OR) (18). The D2.50 allosteric site for sodium ion
binding is highly conserved among class A GPCRs (19). It
forms a pocket that comprises the bound sodium ion and a
cluster of structurally ordered water molecules in the inac-
tive x-ray structures. GPCR activation requires collapse of
the D2.50 allosteric pocket due to a structural rearrangement
of the TM helices, notably the inward displacement of the
NPxxY motif in TM7 (15,19,20).
Along with breakthroughs in GPCR structural studies,
computational simulations have been performed to investi-
gate the conformational dynamics (21–24) and ligand
binding (20,25–27) of GPCRs. Using the specialized super-
computer Anton, deactivation of b2AR from the active x-ray
structure upon removal of the G-protein or its mimetic nano-
body was modeled through microsecond-timescale conven-
tional molecular dynamics (cMD) simulations (21). Anton
simulations of the M2 and M3 receptors captured binding
of antagonist TTP to the extracellular vestibule, but not to
the orthosteric site (6). The ligand-free receptors maintained
the inactive x-ray conformation without a large structural
change (28). The Google Exacycle cloud-computing plat-
form was used to simulate b2AR for a total of 2.15 ms by
combining short cMD runs (24). Markov state models re-
vealed multiple activation pathways of b2AR, and the use
of simulation-derived structures improved molecular dock-
ing of ligand molecules. Moreover, binding of allosteric
modulators to the extracellular vestibule of the M2 receptor
was recently captured in Anton simulations (25). The bind-
ing of a sodium ion to D2.50 and its allosteric effects on the
GPCR dynamics were also investigated for A2AAR (20), the
D2 dopaminergic receptor (26), and m-OR (29). Particularly,
simulations on A2AAR suggested that GPCR activation and
sodium ion binding to the D2.50 allosteric site are mutually
exclusive (20).
For the M3 muscarinic receptor, experimental mutation
of D2.50 to asparagine showed increased binding affinity
of the nitrogen mustard analogs of the acetylcholine and
McN-A-343 agonists (30), suggesting that the D2.50N
mutation biases the M3 receptor toward the active confor-
mational state. Random mutagenesis of the M3 receptor
also suggested a conformational link between the highly
conserved D2.50, R3.50, and Y5.58 residues that is critical
for receptor activation and G-protein coupling (31,32).
Although the protonation state of D2.50 in the M3 receptor
remains unknown, the pKa of D2.50 in b2AR was calcu-
lated from free-energy simulations, suggesting that theprotonated state of D2.50 is favored upon receptor activa-
tion (33). Further long-timescale cMD simulations showed
that the protonated D2.50 biases the conformation of b2AR
toward more active-like states (33). These results are
consistent with a previous experimental finding that both
the basal activity and the level of agonist-induced activation
for b2AR are greater at pH 5 than at pH 8 (34). Therefore,
protonation of D2.50 appears to play an important role in
GPCR activation. In addition, analysis of earlier Anton
cMD simulations of the M2 and M3 muscarinic receptors
(6) using the simulation trajectories provided by DE
Shaw Research showed that sodium ion binding is absent
when D2.50 is protonated (no sodium ion is found within
5 A˚ of the Cg atom of D2.50). A similar finding was ob-
tained when we analyzed our previous accelerated molecu-
lar dynamics (aMD) simulations of the M2 muscarinic
receptor (28). More recent Anton cMD simulations of the
M2 receptor captured sodium ion binding when the D2.50
residue was deprotonated (25). Thus, our goal in this
work was to systematically examine how protonation of
D2.50 affects sodium ion binding and determine the corre-
sponding allosteric effects on activation of a class A GPCR,
particularly the M3 muscarinic receptor.
aMD is a biomolecular, enhanced sampling simulation
technique that often works by adding a nonnegative boost
potential to the potential energy surface, effectively
decreasing energy barriers and thus accelerating transitions
between the low-energy states (35–37). aMD simulations on
timescales of hundreds of nanoseconds have been shown to
capture millisecond-timescale events in proteins (38),
including activation of the M2 receptor (28,39).
In our previous study of the M2 muscarinic receptor, we
demonstrated aMD onGPCR activation (28); here, we inves-
tigate the allosteric effects of sodium ion binding on activa-
tion of the M3 muscarinic receptor through extensive aMD
simulations (total length of 6 ms). Based on the fact that the
M3 receptor exhibits basal activity even without binding
any agonists (5), we removed the cocrystalized ligand from
the x-ray structure for enhanced sampling of the receptor’s
different conformational states. A sodium ion is observed
to bind the deprotonated, but not the protonated, D2.50 resi-
due. Binding of the allosteric sodium ion leads to remarkably
reduced flexibility in the D2.50-deprotonated M3 receptor
that is mostly confined to the inactive state. In contrast, the
D2.50-protonated M3 receptor undergoes activation, sam-
pling a significantly larger conformational space.MATERIALS AND METHODS
aMD
aMD enhances the conformational sampling of functional biomolecules,
often by adding a nonnegative boost potential to the potential energy sur-
face when the system potential is lower than a reference energy (35–37):
VðrÞ ¼ VðrÞ; VðrÞRE;Biophysical Journal 108(7) 1796–1806
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where VðrÞ is the original potential, E is the reference energy, and VðrÞ is
the modified potential. The boost potential DVðrÞ is given byDVðrÞ ¼ ðE VðrÞÞ
2
aþ E VðrÞ; (2)
where a is the acceleration factor. As the acceleration factor a decreases,
the potential energy surface is flattened and biomolecular transitions be-tween the low-energy states are increased.
Dual-boost aMD (37), which has been shown to provide sufficient sam-
pling to capture activation of the M2 receptor (28), is adopted in this study.
A dihedral bias potential is applied to all dihedral angles in the system and
another total boost potential is applied to all individual atoms. The input pa-
rameters (Edihed, adihed; Etotal, atotal) are calculated as
Edihed ¼ Vdihed_avg þ l Vdihed_avg;adihed ¼ l Vdihed_avg

5
Etotal ¼ Vtotal_avg þ n  Natoms;atotal ¼ n  Natoms;
(3)
where Natoms is the total number of atoms; Vdihed_avg and Vtotal_avg are the
average dihedral and total potential energies calculated from short cMDsimulations (e.g., 100 ns in this study), respectively; and l and n are adjust-
able acceleration parameters (previous studies suggested that proper accel-
eration is achieved with l ¼ 0.3 and n ¼ 0.2 for enhanced sampling of
membrane proteins, e.g., activation of the M2 receptor (28,39)).Simulations of the M3 muscarinic receptor
After the ligand was removed from the inactive x-ray structure (Protein
Data Bank (PDB): 4DAJ), the M3 receptor was embedded in a palmitoyl-
oleoyl-phosphatidyl-choline (POPC) lipid bilayer and solvated in an
aqueous medium, with all atoms represented explicitly. The CHARMM27
parameter set was used for the protein (with CMAP terms included)
(40,41), CHARMM36 for POPC lipids (42), and TIP3P model for water
molecules (43). After a 100 ns cMD simulation, we performed two, five,
and three independent 600 ns aMD simulations on the D2.50-deprotonated
receptor in 0.15 M Naþ solution, the D2.50-protonated receptor in 0.15 M
Naþ solution, and the D2.50-protonated receptor without Naþ, respectively
(Table 1). We performed all MD simulations using NAMD2.9 (44). Details
regarding the system preparation and simulation protocols are provided in
the Supporting Material.Simulation analysis
Residue cross correlations of the M3 receptor were calculated based on
mutual information between all Ca atoms in the protein using the general-
ized correlation analysis approach developed by Lange and Grubmu¨ller
(45). A network analysis of the M3 receptor was carried out using the Net-
workView plugin in VMD (46,47). A network graph with each protein res-
idue treated as a node was constructed. Edges were added to the network byTABLE 1 List of cMD and aMD simulations performed on the
M3 muscarinic receptor
System D2.50 [Naþ] Simulation Duration (ns)
1 deprotonated 0.15 M cMD 100
aMD 600  2
2 protonated 0.15 M cMD 100
aMD 600  5
3 protonated – cMD 100
aMD 600  3
Biophysical Journal 108(7) 1796–1806connecting pairs of in-contact nodes, which are defined as having any heavy
atom within 5 A˚ for>75% of the simulation time. Each edge is weighted by
the correlation values of the two end nodes (Cij) as wij ¼ logð
Cij
Þ. The
length of a path between two distant nodes equals the sum of the edge
weights along the path, i.e., D ¼Pi;jwij . The shortest paths (D0) were
computed between residue D2.50 and distant residues in the orthosteric
ligand-binding site (W6.48 and N6.52), intracellular G-protein coupling
site (E6.30, Y5.58, and Y7.53), and extracellular vestibule (F221ECL2,
N6.58, and W7.35). The number of suboptimal paths (Nsop) was calculated
within two distance limits (d ¼ 10 and 20) of the shortest paths.RESULTS
Sodium ion binding and activation of the M3
muscarinic receptor
Starting from the inactive x-ray structure of the M3 receptor
with antagonist TTP removed (Fig. 1 A), residue D2.50
located in the known allosteric site (15) was either deproto-
nated or protonated for separate simulations of the receptor
in 0.15 M Naþ solution. Residue D3.32 located in the or-
thosteric site was deprotonated in all of the simulations. In
an initial 100 ns cMD simulation of the D2.50-deprotonated
system at 310 K, one sodium ion entered the orthosteric site
and then bound to the D2.50 allosteric site (Fig. S1 A), fol-
lowed by a second sodium ion binding to the D3.32 orthos-
teric site (Fig. S1, A and C). In a different 100 ns cMD
simulation of the D2.50-protonated system, no sodium ion
bound to the D2.50 allosteric site, but one bound to the
D3.32 orthosteric site (Fig. S1, B and D).
Using the final structures of the cMD simulations, two
and five independent 600 ns aMD simulations with random-
ized initial atomic velocities at 310 K were performed on the
D2.50-deprotonated and protonated M3 receptor, respec-
tively. In the D2.50-deprotonated system, the two sodium
ions remain bound at the corresponding D2.50 allosteric
and D3.32 orthosteric sites (Figs. 1 B and S2 A), whereas
in the D2.50-protonated system, only one sodium ion re-
mains bound to the D3.32 orthosteric site (Figs. 1 C and
S2 B). In addition, three independent 600 ns aMD simula-
tions were performed on the D2.50-protonated receptor in
the absence of Naþ for comparison (Table 1).
During a 600 ns aMD simulation of the D2.50-deproto-
nated receptor, a sodium ion is bound to the D2.50 side
chain at an average distance of 2.8 A˚ to the Cg atom with
slight fluctuations (0.4 A˚ standard deviation (SD); Fig. 1
B). The second sodium ion remains at an average distance
of 2.7 A˚ to the Cg atom of D3.32 with a 0.3 A˚ SD
(Fig. S2 A). The distance between the hydroxyl oxygens
of Y5.58 and Y7.53 stays above 8 A˚, being similar to the
Y5.58-Y7.53 distance observed in the inactive x-ray struc-
tures of the M2 and M3 receptors (12.6 A˚ and 15.6 A˚,
respectively) and significantly greater than that of the active
M2 structure (4.2 A˚). The distance between the Ca atoms of
residues R3.50 and A6.34 in the cytoplasmic ends of TM3
and TM6 remains mostly at ~8 A˚ and increases up to
~13 A˚ during short periods of time near ~180 ns and
FIGURE 1 Activation and mechanistic effects of sodium ion binding of the M3 muscarinic receptor simulated via aMD. (A) Schematic representation of
the M3 receptor (orange ribbons) with two sodium ions (yellow spheres) bound to the D3.32 orthosteric and D2.50 allosteric sites. Key residues, including
D2.50, D3.32, R3.50, A6.34, W6.48, N6.58, Y5.58, Y7.53, and F221ECL2, are shown in sticks, and the two highly conserved DRY and NPxxY motifs are
highlighted in purple. Three residues that are missing in the x-ray structure (K6.31A6.33) are added and shown in gray. (B) In the D2.50-deprotonated
receptor in 0.15 M Naþ solution, two sodium ions bind to the D2.50 allosteric and D3.32 orthosteric sites, respectively. (C) In the D2.50-protonated receptor
in 0.15 M Naþ solution, only one sodium binds to the D3.32 orthosteric site. (D) A third system with D2.50 protonated is simulated in the absence of Naþ.
The distances of bound sodium ion(s) to the Cg atom of D2.50 are plotted in (B) and (C). The corresponding distances between Y5.58 and Y7.53 (hydroxyl
oxygens) and between R3.50 and A6.34 (Ca atoms) are plotted for each of the three simulated systems. Thick lines depict the running average over 1 ns
(simulation frames were saved every 10 ps for the original). The Y5.58-Y7.53 and R3.50-A6.34 distances in the inactive x-ray structure of the M3 receptor
(PDB: 4DAJ) are plotted in the solid green line and those of the inactive and active structures of the M2 receptor (PDB: 3UON and 4MQS, respectively) are
plotted in dashed green and red lines, respectively. The R3.50-A6.34 distance is reported only when helical structure is formed up to residue A6.34 in the
TM6 intracellular region (Fig. S3). The RMSD of the NPxxY motif between the active and inactive structures of the M2 receptor (3.6 A˚) is also plotted in a
dashed red line. Red rectangles highlight activation events of the M3 receptor in (C) and (D). To see this figure in color, go online.
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1800 Miao et al.~420 ns. Note that the R3.50-A6.34 distance is reported
only when helical structure is formed up to residue A6.34
in the TM6 intracellular region (Fig. S3), which has three
residues (K6.31–A6.33) missing and adopts a random coil
conformation in the x-ray structure (Fig. 1 A). For the
NPxxY motif, the average root mean-square deviation
(RMSD) of the M3 receptor relative to the inactive x-ray
conformation is 2.3 A˚, which is lower than the 3.6 A˚
RMSD calculated between the active and inactive x-ray
structures of the M2 receptor. When the two independent
600 ns aMD simulations of the D2.50-deprotonated receptor
in 0.15 M Naþ solution (1200 ns in total) are combined, cal-
culations of the potential of mean force (PMF) show that the
R3.50–A6.34 distance possesses an energy minimum at
7.0 A˚ (Fig. S4 A) and the Y5.58-Y7.53 hydrogen bond stays
in the fully open conformation with a broad energy well at
~1216 A˚ (Fig. S4 C). Therefore, the D2.50-deprotonated
M3 receptor that is bound by the allosteric sodium ion
does not visit a conformation similar to the active M2
receptor.
In contrast, sodium ion binding to the D2.50 allosteric site
is absent during a 600 ns aMD simulation of the D2.50-pro-
tonated M3 receptor (Fig. 1 C). The only sodium ion that
enters the orthosteric site remains bound to the D3.32 side
chain at 2.9 A˚ average distance with small fluctuations of
0.6 A˚ SD (Fig. S2 B). The side chains of Y5.58 and
Y7.53 are able to move toward each other, forming close
interaction briefly at 3.0 A˚ distance between the two hydrox-
yl oxygens during 260-300 ns of the aMD simulation (Fig. 1
C). Meanwhile, the distance between the Ca atoms of R3.50
and A6.34 increases from 7.5 A˚ to ~14 A˚ due to outward tilt-
ing of the TM6 cytoplasmic end. Furthermore, the NPxxY
motif moves inward with an ~4 A˚ RMSD relative to the
inactive x-ray conformation, due to rearrangement of the
TM7 cytoplasmic end (Fig. 1 C). PMF calculations using
a combined trajectory of the five independent 600 ns aMD
simulations (3000 ns in total) show that the Y5.58-Y7.53
hydrogen bond visits the closed and water-bridged confor-
mation with local energy wells centered at 3.0 A˚ and
4.5 A˚, respectively (Fig. S4 D). Although the R3.50-A6.34
distance mostly adopts the closed conformation with
the energy minimum found at 8.0 A˚, it samples a fully
open conformation with a second energy well centered at
~15 A˚ (Fig. S4 B), which corresponds to outward tilting
of the TM6 cytoplasmic end. Even without reweighting of
the aMD simulations, the free energy of the fully open
conformation of R3.50-A6.34 (active) is ~1.5 kcal/mol
greater than that of the closed (inactive) conformation,
and the closed and water-bridged conformation of the
Y5.58-Y7.53 hydrogen bond (active) is ~3.0 kcal/mol
greater than that of the fully open (inactive) conformation.
These results suggest that the receptor active state with
significantly higher free energies is less stable than the inac-
tive state. Further PMF calculations of the distance between
F221ECL2 and N6.58 in the extracellular vestibule show thatBiophysical Journal 108(7) 1796–1806in addition to the energy minimum at ~13–14 A˚, it visits a
second energy well centered at ~9 A˚ in the D2.50-proton-
ated M3 receptor (Fig. S4 F), suggesting a narrowing of
the extracellular mouth. These structural changes resemble
those observed in activation of the M2 receptor (13,28),
b2AR (11,12), and rhodopsin (7,8). Therefore, activation
of the M3 receptor is captured in an aMD simulation of
the D2.50-protonated form without sodium ion binding to
the D2.50 allosteric site.
For further comparison, three independent 600 ns aMD
simulations were also obtained on the D2.50-protonated
M3 receptor in the absence of Naþ. The results show that
the distance between the hydroxyl oxygens of Y5.58 and
Y7.53 decreases to 4.5 A˚ at ~590 ns, accompanied by an
increased distance between the Ca atoms of R3.50 and
A6.34 to ~17 A˚ (Fig. 1 D). Meanwhile, the RMSD of the
NPxxY motif relative to the inactive x-ray conformation in-
creases to ~3 A˚. The D2.50-protonated M3 receptor still un-
dergoes activation in the absence of Naþ, suggesting that
activation of the M3 receptor is independent of sodium
ion binding to the D3.32 orthosteric site.Remarkably reduced flexibility of the M3 receptor
upon sodium ion binding to D2.50
Here, we examined the mechanistic effects of sodium ion
binding on the structural flexibility and dynamic motions
of the M3 receptor. Calculations on the root mean-square
fluctuations (RMSFs) of the receptor Ca atoms show that
the D2.50-protonated form undergoes similar residue fluctu-
ations in 0.15 M Naþ solution or in the absence of Naþ,
despite small differences observed in the TM1, TM2, and
TM3 regions (Fig. 2 A). In comparison, the D2.50-deproto-
nated M3 receptor with sodium ion bound to the D2.50 allo-
steric site exhibits a remarkably reduced flexibility, by
~30% on average, particularly in the TM3, TM4, TM5,
TM6, and TM7 helices. Thus, the D2.50-deprotonated re-
ceptor is less likely to be activated because the structural re-
arrangement of these TM helices is highly involved in
activation of class A GPCRs (11,13).
Fig. 2 B plots the generalized cross correlations of residue
motions in the D2.50-deprotonated M3 receptor compared
with the D2.50-protonated form, both of which were placed
in the 0.15 M Naþ solution. In the D2.50-deprotonated
form, although the residue motions in the extracellular re-
gion of TM3 and the ECL2 between the TM4 and TM5
extracellular ends exhibit correlations higher than 0.6,
largely due to the presence of a disulphide bond connecting
the two regions, the residue motions of other regions possess
correlations lower than 0.6. Overall, the D2.50-protonated
receptor undergoes increased correlated motions, with cor-
relations between most TM helices being greater than 0.6
(Fig. 2 B). Notably, the TM2 helix, which is not stabilized
by the allosteric sodium ion binding as in the D2.50-depro-
tonated system, exhibits higher correlations with the TM3,
FIGURE 2 (A) The RMSFs of the M3 receptor were calculated by averaging the multiple independent 600 ns aMD simulations of the D2.50-deprotonated
system in 0.15 M Naþ solution, the D2.50-protonated system in 0.15 M Naþ solution, and the D2.50-protonated system in the absence of Naþ. (B) Gener-
alized cross correlations of residue motions in the D2.50-deprotonated receptor (lower triangle) compared with the D2.50-protonated (upper triangle) in
0.15 M Naþ solution. Orange bars denote the seven TM helices (TM1–TM7). To see this figure in color, go online.
M3 GPCR Activation and Sodium Binding 1801TM4, TM5, and TM7 helices. Moreover, correlations
among the TM3, TM4, TM5, TM6, and TM7 helices are
increased by ~0.25 on average. The D2.50-protonated M3
receptor in the absence of Naþ shows similar increased res-
idue correlations relative to the D2.50-deprotonated form
with a sodium ion bound to the D2.50 allosteric site
(Fig. S5). This is consistent with earlier findings that the
apo M2 receptor (with D2.50 protonated) undergoes activa-
tion in the ligand-free form and exhibits significantly higher
correlations of residue motions than in the antagonist-bound
form, which maintains the inactive x-ray conformation (28).
Correlated motions of the TM helices play a key role in acti-
vation and signaling of class A GPCRs.Confined conformational space of the M3
receptor with sodium ion binding to D2.50
We further examined the conformational space sampled by
the D2.50-deprotonated M3 receptor using the R3.50-A6.34
and Y5.58-Y7.53 distances as two reaction coordinates.
With sodium ion bound to the D2.50 allosteric site, the
M3 receptor mostly stays in the inactive state, with only
transient visiting of an intermediate conformation (denoted
IM (D2.50-COO)), which exhibits an increased distance
between R3.50 and A6.34 as shown in Fig. 3 A.
A representative inactive conformation of the D2.50-de-
protonatedM3 receptor is depicted in Fig. 3B. It largely over-
laps with the inactive x-ray structure. The distance between
R3.50 and A6.34 is 7.3 A˚ and the side chain of Y7.53 points
toward Naþ in the D2.50 allosteric pocket. Marked structural
changes are observed in the TM6 intracellular region, which
forms an a helix in ~60 ns of aMD simulation time (Fig. S3
A). Moreover, Y5.58 in the TM5 cytoplasmic end is able
to reorient the side chain from the lipid-exposed surface to
the interface between TM5 and TM6 helices in a slightly
different inactive conformation (Fig. S6).In the IM (D2.50-COO) intermediate, the TM6 cyto-
plasmic end moves toward TM7, with the distance between
R3.50 and A6.34 increasing to 13.5 A˚ (Fig. 3C). Meanwhile,
the NPxxY motif in TM7 tilts outward by ~3 A˚ and Y7.53
flips the side chain from pointing toward Naþ in the D2.50
allosteric pocket to pointing toward the cytoplasmic solvent.
This intermediate appears to result from the mobile nature of
the TM6 cytoplasmic end identified in class A GPCRs (48).
However, the presence of a sodium ion in the D2.50 allosteric
pocket hinders inward movement of the NPxxY motif in
TM7 (particularly reorientation of the Y7.53 side chain)
and thus prohibits activation of the M3 receptor.Activation of the M3 receptor without sodium ion
binding to D2.50
In the absence of sodium ion binding to the D2.50 allosteric
site, the D2.50-protonated M3 receptor samples a signifi-
cantly larger conformational space compared with the
D2.50-deprotonated form, since it is able to escape out of
the inactive state and visit several distinct conformational
states (Fig. 4 A). Of particular interest, the M3 receptor
visits an active conformational state that resembles the
x-ray structures of active GPCRs, including the M2 receptor
(13,28), b2AR (11,12), and opsin (7,8).
During activation of the D2.50-protonated receptor in
0.15MNaþ solution, the TM6 cytoplasmic end tilts outward
by ~6 A˚ (Fig. 4B). ResidueY5.58 flips the side chain from the
lipid-exposed surface to the interface between TM5 and
TM6, and Y7.53 also reorients the side chain toward Y5.58
with ~4 A˚ inward displacement of the NPxxY motif in
TM7. Subsequently, the two tyrosines form a hydrogen
bond at a 3.0 A˚ distance between the hydroxyl oxygens. An
intermediate conformation that appears in the receptor acti-
vation pathway, IM-1, is shown in Fig. 4C. In this conforma-
tion, Y7.53 flips the side chain from pointing toward theBiophysical Journal 108(7) 1796–1806
FIGURE 3 (A) Conformational space sampled by the D2.50-deprotonated M3 receptor during a 600 ns aMD simulation with sodium ion binding to the
D2.50 allosteric site. Related GPCR x-ray structures, including the inactive M3 (PDB: 4DAJ), inactive M2 (PDB: 3UON), active M2 coupled by a G-protein-
mimetic nanobody (PDB: 4MQS), active b2AR coupled by a Gs protein (PDB: 3SN6) or its mimetic nanobody (PDB: 3P0G), and opsin (active rhodopsin)
with or without the C-terminal peptide of the Ga subunit (PDB: 3DQB and 3CAP, respectively) are marked for comparison. (B and C) The representative
inactive (B, green) and intermediate IM (C2.50-COO) (C, blue) conformations are compared with the x-ray structure (orange). Key residues, the DRYand
NPxxY motifs, and sodium ions are shown similarly as described in Fig. 1 A. To see this figure in color, go online.
1802 Miao et al.D2.50 allosteric site to pointing toward the cytoplasmic sol-
vent as observed in the IM (D2.50-COO) conformation.
Moreover, Y5.58 slides its side chain into the space that is
originally occupied by the TM6 cytoplasmic end, leading
to a large outward tilting of the latter at a distance of ~16 A˚
between R3.50 and A6.34 (Fig. 4 C). Additionally, the
D2.50-protonated receptor visits a second intermediate,
IM-2, which exhibits less outward tilting of the TM6 cyto-
plasmic end (~12 A˚ distance between R3.50 and A6.34)
compared with IM-1. In the IM-2 intermediate, the Y5.58
side chain remains on the lipid-exposed surface as observed
in the x-ray structure, whereas Y7.53 reorients the side chain
toward the cytoplasmic solvent as in IM-1 or IM (D2.50-
COO) (Fig. 4 D). Activation of the M3 receptor and both
IM-1 and IM-2 intermediate conformations are also observed
in an aMD simulation of theD2.50-protonated receptor in the
absence of Naþ, during which the Y5.58 and Y7.53 side
chains form a water-bridged hydrogen-bonding interaction
at a 4.5 A˚ distance between the two hydroxyl oxygens, and
the TM6 cytoplasmic end tilts outward at a larger magnitude
in the active conformation (~14 A˚) (Fig. S7).
During the last 50 ns of the aMD simulation of the D2.50-
protonated receptor in 0.15 M Naþ solution, a distinct
conformation is observed, with the Y5.58-Y7.53 distance
increasing significantly to ~30 A˚ (see Figs. 1 C and 4 A).
This is largely due to the outward displacement of the mo-
bile TM5 cytoplasmic end and flipping of the Y5.53 side
chain away from the TM bundle (Fig. 4 E). Such a structural
change can potentially lead to a large opening between the
cytoplasmic ends of TM5 and TM6, and exposure of the
third intracellular loop (ICL3). Since earlier site-directed
mutagenesis experiments identified phosphorylation sites
of GPCR in ICL3 (two clusters of Ser/Thr residues)
(49,50), this conformation (denoted PL) may be relevant
for coupling of GPCR with protein kinases for phosphoryla-
tion and arrestin binding. However, this strongly requires
experimental validation, ideally with a high-resolution
structure of arrestin-coupled GPCR. This observation isBiophysical Journal 108(7) 1796–1806consistent with a previous finding regarding the M2 recep-
tor, which also samples a similar conformational state dur-
ing aMD simulations (28).Network changes induced by sodium ion binding
To understand the effects of sodium ion binding on receptor
allosteric signaling, we obtained dynamic networks for both
the D2.50-protonated and D2.50-deprotonated M3 musca-
rinic receptor (see Materials and Methods). Previous studies
on A2AAR and b2AR suggested that activation of GPCRs in-
volves a collapse of the sodium-ion-binding pocket located
at the D2.50 residue (19). Further simulations identified that
protonation of the D2.50 residue shifts the conformation of
the b2AR toward more active-like states (33). Therefore, we
determined the shortest paths and number of suboptimal
paths (Nsop) between residue D2.50 and distant residues in
the orthosteric ligand-binding site (W6.48 and N6.52), the
intracellular G-protein coupling site (E6.30, Y5.58, and
Y7.53), and the extracellular vestibule (F221ECL2, N6.58,
and W7.35) (Fig. 5). The shortest distances and Nsop values
are summarized in Table 2.
Overall, the shortest signaling distances between residue
D2.50 and distant residues in the D2.50-deprotonated recep-
tor bound by sodium ion are greater than those in the D2.50-
protonated M3 receptor, except for interactions with the
Y5.58 and F221ECL2 residues (Table 2). This suggests
higher correlations between nodes along the shortest paths
in the D2.50-protonated receptor. Furthermore, the D2.50-
protonated receptor possesses a significantly larger number
of degenerate suboptimal paths than the D2.50-deprotonated
receptor. A similar trend was obtained for Nsop within two
distance limits (d ¼ 10 and 20) of the shortest paths.
In addition, we compared the two D2.50-protonated and
D2.50-deprotonated receptor forms regarding their network
interactions involving key residues in the extracellular ves-
tibule and orthosteric ligand-binding site (N6.58, W7.35,
W6.48, and N6.52), and in the intracellular G-protein
FIGURE 4 (A) Conformational space sampled by the D2.50-protonated M3 receptor in 0.15 M Naþ solution during a 600 ns aMD simulation. Related
GPCR x-ray structures are marked similarly as in Fig. 3 A. (B–E) Intracellular view of different conformers of the M3 receptor that might be relevant
for GPCR phosphorylation are compared with the x-ray structure (orange): (B) active (red), (C) IM-1 intermediate (blue), (D) IM-2 intermediate (pink),
and (E) PL (purple). To see this figure in color, go online.
M3 GPCR Activation and Sodium Binding 1803coupling site (E6.30, Y5.58, and Y7.53) (Table S1). Similar
to the above findings, the D2.50-protonated receptor shows
decreased distances and an increased number of suboptimal
paths for signaling relative to the D2.50-deprotonated re-
ceptor. Therefore, the receptor exhibits stronger allosteric
signaling during activation in the D2.50-protonated form.
Such allosteric signaling is greatly weakened in the
D2.50-deprotonated M3 receptor upon sodium ion binding.DISCUSSION
Comparison with activation of the M2 muscarinic
receptor
The representative active conformations of the M3 receptor
observed during aMD simulations of the D2.50-protonated
form are compared with the x-ray structure of the active
M2 receptor in Fig. S8. The orientation of the Y5.58
and Y7.53 side chains in the simulation-derived active M3receptor is very similar to that of the active M2 x-ray struc-
ture, accompanied by a similar inward movement of the
NPxxY motif in TM7. Relative to the inactive x-ray struc-
tures, the TM6 cytoplasmic end moves outward in both
the active M3 and M2 receptors, although the displacement
magnitude varies. In the active x-ray structure of the M2 re-
ceptor that is bound by agonist iperoxo and a G-protein
mimetic nanobody, the TM6 cytoplasmic end tilts outward
by 10.4 A˚ compared with the inactive antagonist-bound
x-ray structure (13). In active conformations of the M3 re-
ceptor, the TM6 cytoplasmic end moves outward by ~6 A˚
in aMD simulations of the D2.50-protonated receptor in
0.15 M Naþ solution and ~14 A˚ in the absence of Naþ.
Different displacement magnitudes of the TM6 cytoplasmic
end have also been observed in the active x-ray structures of
opsin (~6–7 A˚) (7,8), b2AR coupled by the Gs protein (14 A˚)
(11), and a G-protein mimetic nanobody (11.4 A˚) (12).
These findings suggest that the TM6 cytoplasmic end is
highly mobile in class A GPCRs. It is able to move outwardBiophysical Journal 108(7) 1796–1806
FIGURE 5 (A and B) The shortest paths be-
tween residue D2.50 and topographically distant
residues obtained from network analysis of the
(A) D2.50-protonated and (B) D2.50-deprotonated
M3 receptor in 0.15 M Naþ solution. The analyzed
signaling residues include W6.48 and N6.52 in the
orthosteric ligand-binding site; E6.30, Y5.58, and
Y7.53 in the intracellular G-protein-coupling site;
and F221ECL2, N6.58, and W7.35 in the extracel-
lular vestibule. The edge thickness is set propor-
tional to the number of suboptimal paths (Nsop)
obtained within the d ¼ 10 distance limit of the
shortest paths as listed in Table 2. To see this figure
in color, go online.
1804 Miao et al.across a wide range of magnitudes, from ~6 A˚ to ~14 A˚. The
presence of an intracellular G-protein or a G-protein
mimetic nanobody is likely to stabilize GPCRs in an active
conformation, with a larger outward displacement of the
TM6 cytoplasmic end (e.g., x-ray structures of the active
b2AR and M2 receptor) compared with one without the
intracellular counterpart (e.g., opsin).
In addition, we compared the primary sequence of the rat
M3 receptor studied here with the five subtypes of musca-
rinic receptors (Fig. S9). Notably, both the inactive and
active x-ray structures have been determined for the human
M2 receptor (13,51). Excluding the bulk of ICL3 that is
missing in the x-ray structures, 81% of the protein residues
are highly conserved between the M3 and M2 receptors.TABLE 2 The shortest distance (D0) and number of
suboptimal paths (Nsop) obtained from network analysis of the
D2.50-deprotonated and D2.50-protonated M3 receptor
between residue D2.50 and distant residues in the intracellular


















W6.48 166 2 3 210 1 1
N6.52 170 8 24 235 1 5
Intracellular E6.30 340 5 28 349 2 2
Y5.58 290 12 94 205 2 12
Y7.53 82 3 14 99 2 5
Extracellular F221ECL2 638 24 150 276 5 15
N6.58 161 9 33 259 4 17
W7.35 105 3 5 170 1 3
The Nsop was calculated within two distance limits (d ¼ 10 and 20) of the
shortest paths.
Biophysical Journal 108(7) 1796–1806High sequence similarity is also identified between the
M3 receptor and the M5 (93%), M1 (89%), and M4 (83%)
subtypes. Such high similarity suggests a common structural
scaffold for the seven TM helices, and similar activation
mechanisms in the muscarinic receptors. This includes the
characteristic conformational changes in the R3.50-E6.30
ionic lock and the Y5.58-Y7.53 hydrogen bond during acti-
vation, as well as binding of a sodium ion to the highly
conserved D2.50 residue. However, 19% of the protein
residues differ between the M2 and M3 receptors. These res-
idues are mostly distributed on the receptor surface (Fig. S9
A). Notably, 10 and six residues are not conserved in the
intracellular regions of the TM5 and TM6 helices, respec-
tively. This is correlated with the high mobility of the
TM5 and TM6 cytoplasmic ends, which have been crystal-
ized in different configurations in the GPCR x-ray struc-
tures. For example, the TM5 cytoplasmic end in the
inactive x-ray structure of the M3 receptor exhibits an
~4 A˚ inward displacement compared with the inactive M2
structure, along with a distinct orientation of the Y5.58
side chain (6,51). Low conservation of residues in the
TM6 cytoplasmic end could also contribute to its different
displacement magnitude in the GPCR active conformations.Sodium ion binding and the allosteric effects
Previous microsecond-timescale cMD simulations captured
sodium ion binding to residue D2.50 in the D2 receptor and
identified three low-energy sites along the binding pathway:
the D3.32 orthosteric pocket, a cavity near W6.48, and the
D2.50 allosteric pocket (26). Such sodium ion binding to
the D2.50 allosteric site was also observed in cMD simula-
tions of m-OR (29). In addition, binding of sodium ion in the
D2.50 allosteric pocket was determined in x-ray structures
M3 GPCR Activation and Sodium Binding 1805of the inactive A2AAR (15), b1AR (16), PAR1 (17), and
d-OR (18). It has been suggested that the muscarinic
receptors possess a more open passage for sodium access
compared with A2AAR and b1AR (19). In earlier simula-
tions of the M2 muscarinic receptor, sodium ion was
observed to bind to the deprotonated D2.50 residue (25),
but this did not occur when residue D2.50 was protonated
(6,28). In this study, we observed similar results in simula-
tions of the M3 muscarinic receptor. In the D2.50-proton-
ated M3 receptor, no sodium ion bound to the D2.50
allosteric site. In contrast, in the D2.50-deprotonated M3
receptor, one sodium ion diffused into the orthosteric site
and then bound to the D2.50 allosteric site during a
100 ns cMD simulation. Therefore, sodium ion binding to
the highly conserved D2.50 residue appears to a common
characteristic of class A GPCRs.
Earlier 100-ns-timescale cMD simulations on A2AAR
suggested that activation of A2AAR and sodium ion binding
that greatly stabilizes the D2.50 allosteric pocket are mutu-
ally exclusive (20). Recent microsecond-timescale cMD
simulations and free-energy calculations of b2AR identified
that protonation of the D2.50 residue shifts the conforma-
tion of the b2AR toward more active-like states (33).
Here, our extensive aMD simulations reveal that the
D2.50-deprotonated M3 receptor with sodium ion bound
stays in the inactive state, with only transient visiting of
an intermediate conformation. In comparison, the D2.50-
protonated M3 receptor samples a significantly larger
conformational space, visiting an active state that resembles
the active x-ray structures of the M2 receptor (13), b2AR
(11,12), and opsin (7,8). Activation of the M3 receptor is
characterized by outward tilting of the TM6 cytoplasmic
end, formation of a close interaction between the Y5.58
and Y7.53 side chains, and inward displacement of the
NPxxY motif in the TM7 intracellular region. Large corre-
lations of residue motions and strong allosteric network
interactions between distant regions in the receptor play
important roles during activation of the M3 muscarinic
receptor.CONCLUSIONS
In this study, we investigated the mechanistic effects of so-
dium ion binding on activation of the M3 receptor through
long-timescale aMD simulations. We performed aMD simu-
lations (6 ms long in total) on the receptor, with different
protonation of the D2.50 allosteric site and sodium ion con-
centration. During the aMD simulations, the formation of
an a helix is observed in the intracellular region of the
TM6 helix, which is missing three residues (K6.31A6.33)
and adopts a random coil conformation for residues
A6.34L6.37 in the x-ray structure. The TM6 intracellular
region remained in a random coil conformation throughout
our initial cMD simulations, illustrating the enhanced sam-
pling power of aMD. Although aMD suffers from high ener-getic noise in simulations of large proteins such as GPCRs,
and accurate reweighting to recover their original free-en-
ergy landscape remains challenging (39), our extensive
aMD simulations provide sufficient conformational sam-
pling of the M3 muscarinic receptor to reveal key conforma-
tional transitions. Activation is captured in the highly flexible
D2.50-protonated M3 receptor, which exhibits large residue
correlations and a strong allosteric network. When the D2.50
residue is deprotonated, the M3 receptor is bound by an allo-
steric sodium ion and is confined mostly in the inactive state,
with remarkably reduced flexibility. The strength of network
interactions among the D2.50 allosteric pocket, extracellular
vestibule, orthosteric ligand-binding site, and intracellular
G-protein coupling site is greatly weakened upon sodium
ion binding to the D2.50 residue.SUPPORTING MATERIAL
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